Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study

dc.contributor.author	Kattamis, A.
dc.contributor.author	Karakas, Zeynep
dc.contributor.author	Siritanaratkul, N.
dc.contributor.author	Wang, C.
dc.contributor.author	Lai, Y.
dc.contributor.author	Taher, A. T.
dc.contributor.author	Cappellini, M.
dc.contributor.author	Aydinok, Y.
dc.contributor.author	Porter, J.
dc.contributor.author	Viprakasit, V.
dc.date.accessioned	2021-03-05T17:45:43Z
dc.date.available	2021-03-05T17:45:43Z
dc.identifier.citation	Taher A. T. , Cappellini M., Aydinok Y., Porter J., Karakas Z., Viprakasit V., Siritanaratkul N., Kattamis A., Wang C., Lai Y., "Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study", AABB Annual Meeting, Florida, Amerika Birleşik Devletleri, 22 - 25 Ekim 2016, cilt.56
dc.identifier.other	vv_1032021
dc.identifier.other	av_c7237d31-d068-4f7c-b651-3f19da3771ad
dc.identifier.uri	http://hdl.handle.net/20.500.12627/131989
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Hematoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Klinik Tıp
dc.subject	HEMATOLOJİ
dc.title	Optimizing Iron Chelation Therapy with Deferasirox in Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Phase 4, Open-Label THETIS Study
dc.type	Bildiri
dc.contributor.department	American University of Beirut , ,
dc.identifier.volume	56
dc.contributor.firstauthorID	149929

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.